Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm

Author:

Greenberg Barry1,Neaton James D.2,Anker Stefan D.34,Byra William M.5,Cleland John G. F.67,Deng Hsiaowei5,Fu Min8,La Police David A.5,Lam Carolyn S. P.91011,Mehra Mandeep R.12,Nessel Christopher C.5,Spiro Theodore E.13,van Veldhuisen Dirk J.11,Vanden Boom Catherine M.5,Zannad Faiez1415

Affiliation:

1. Cardiology Division, Department of Medicine, University of California, San Diego, La Jolla

2. Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis

3. Berlin–Brandenburg Center for Regenerative Therapies, Berlin, Germany

4. Department of Cardiology, German Center for Cardiovascular Research partner site Berlin, Charite Universitatsmedizin Berlin, Berlin, Germany

5. Janssen Research and Development, Raritan, New Jersey

6. Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Glasgow, Scotland

7. National Heart and Lung Institute, Imperial College London, London, England

8. Janssen Research and Development, Spring House, Pennsylvania

9. National Heart Centre Singapore, Singapore

10. Duke-National University of Singapore, Singapore

11. Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

12. Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

13. Research and Development, Pharmaceuticals, Thrombosis and Hematology Therapeutic Area, Bayer US, Whippany, New Jersey

14. Universite de Lorraine, INSERM Unite 1116, Vandoeuvre les Nancy, France

15. Clinical Investigation Center 1433, French Clinical Research Infrastructure Network, Investigation Network Initiative–Cardiovascular and Renal Clinical Trialists, Centre Hospitalier Regional et Universitaire de Nancy, Vandoeuvre les Nancy, France

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3